Effect of cool vs. warm dialysate on toxin removal: rationale and study design

Vaibhav Maheshwari, Titus Lau, Lakshminarayanan Samavedham, Gade P Rangaiah, Vaibhav Maheshwari, Titus Lau, Lakshminarayanan Samavedham, Gade P Rangaiah

Abstract

Background: Cool dialysate is often recommended for prevention of intra-dialytic hypotensive episodes in maintenance hemodialysis (HD) patients. However, its effect on toxin removal is not studied. It is known that inter-compartmental resistance is the main barrier for toxin removal. Cool dialysate can potentially increase this resistance by vasoconstriction and thus impair the toxin removal. The aim of this trial is to compare the toxin removal outcome associated with cool vs. warm dialysate.

Method/design: This study is based on the hypothesis that dialysate temperature, a potential maneuver to maintain hemodynamic stability during HD, may influence inter-compartmental resistance and hence, toxin removal. Only stable HD patients will be recruited for this study. The quantum of removed toxins will be assessed by the total spent dialysate, which is a gold standard to quantify the efficacy of a single dialysis session. Collected samples will be analyzed for urea, creatinine, phosphate, β2-microglobulin, and uric acid. The study is a single center, self-controlled, randomized prospective clinical research where 20 study subjects will undergo 2 dialysis sessions: (a) cool dialysis with dialysate at 35.5°C, and (b) warm dialysis with dialysate at 37°C. Pre- and post-dialysis blood samples will be collected to quantify the dialysis adequacy and toxin reduction ratio.

Discussion: This is the first clinical research to investigate the effect of dialysate temperature on removal of both small and large-sized toxins. Successful completion of this research will provide important knowledge pertaining to dialysate temperature prescription. Results can also lead to the hypothesis that cool dialysate may help in by preventing intra-dialytic hypotensive episodes, but prolonged prescription of cool dialysate may lead to comorbidities associated with excess toxin accumulation. The new knowledge will encourage for personalized dialysate temperature profiling.

Trial registration: Clinicaltrials.gov Identifier--NCT02064153.

Figures

Figure 1
Figure 1
Schematic flow diagram of the clinical study.

References

    1. Ward RA, Greene T, Hartmann B, Samtleben W. Resistance to intercompartmental mass transfer limits beta(2)-microglobulin removal by post-dilution hemodiafiltration. Kidney Int. 2006;69(8):1431–7.
    1. Maheshwari V, Samavedham L, Rangaiah G. A regional blood flow model for β2-microglobulin kinetics and for simulating intra-dialytic exercise effect. Ann Biomed Eng. 2011;39(12):2879–90. doi: 10.1007/s10439-011-0383-5.
    1. Maheshwari V, Samavedham L, Rangaiah GP, Loy Y, Hsi LL, Sethi S, et al. Comparison of toxin removal outcomes in online hemodiafiltration and intra-dialytic exercise in high-flux hemodialysis: a prospective randomized open-label clinical study protocol. BMC Nephrol. 2012;13(1):156. doi: 10.1186/1471-2369-13-156.
    1. Selby NM, McIntyre CW. A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant. 2006;21(7):1883–98. doi: 10.1093/ndt/gfl126.
    1. Damasiewicz MJ, Polkinghorne KR. Intra-dialytic hypotension and blood volume and blood temperature monitoring. Nephrology. 2011;16(1):13–8. doi: 10.1111/j.1440-1797.2010.01362.x.
    1. Dheenan S, Henrich WL. Preventing dialysis hypotension: a comparison of usual protective maneuvers. Kidney Int. 2001;59(3):1175–81. doi: 10.1046/j.1523-1755.2001.0590031175.x.
    1. Yu AW, Ing TS, Zabaneh RI, Daugirdas JT. Effect of dialysate temperature on central hemodynamics and urea kinetics. Kidney Int. 1995;48(1):237–43. doi: 10.1038/ki.1995.289.
    1. Levin N, Morris A, Lavarias V, Wang Y, Glabman M, Leung J, et al. Effects of body core temperature reduction on haemodynamic stability and haemodialysis efficacy at constant ultrafiltration. Nephrol Dial Transplant. 1996;11(supp2):31. doi: 10.1093/ndt/11.supp2.31.
    1. Vanholder R, Eloot S, Van Biesen W. Do we need new indicators of dialysis adequacy based on middle-molecule removal? Nat Clin Pract Nephrol. 2008;4(4):174–5. doi: 10.1038/ncpneph0750.
    1. Duranton F, Depner TA, Argiles A. The saga of two centuries of urea: nontoxic toxin or vice versa? Semin Nephrol. 2014;34(2):87–96. doi: 10.1016/j.semnephrol.2014.02.002.
    1. George TO, Priester-Coary A, Dunea G, Schneditz D, Tarif N, Daugirdas JT. Cardiac output and urea kinetics in dialysis patients: evidence supporting the regional blood flow model. Kidney Int. 1996;50(4):1273–7. doi: 10.1038/ki.1996.438.
    1. Schneditz D, Van Stone JC, Daugirdas JT. A Regional blood circulation alternative to in-series two compartment urea kinetic modeling. ASAIO J. 1993;39(3):M573–7. doi: 10.1097/00002480-199339030-00079.
    1. Schneditz D, Platzer D, Daugirdas JT. A diffusion-adjusted regional blood flow model to predict solute kinetics during haemodialysis. Nephrol Dial Transplant. 2009;24(7):2218–24. doi: 10.1093/ndt/gfp023.
    1. Eloot S, Torremans A, De Smet R, Marescau B, De Wachter D, De Deyn PP, et al. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int. 2005;67(4):1566–75. doi: 10.1111/j.1523-1755.2005.00238.x.
    1. Eloot S, Torremans A, De Smet R, Marescau B, De Deyn PP, Verdonck P, et al. Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis. 2007;50(2):279–88. doi: 10.1053/j.ajkd.2007.05.009.
    1. Barth C, Boer W, Garzoni D, Kuenzi T, Ries W, Schaefer R, et al. Characteristics of hypotension‐prone haemodialysis patients: is there a critical relative blood volume? Nephrol Dial Transplant. 2003;18(7):1353. doi: 10.1093/ndt/gfg171.
    1. Jost CM, Agarwal R, Khair-el-Din T, Grayburn PA, Victor RG, Henrich WL. Effects of cooler temperature dialysate on hemodynamic stability in “problem” dialysis patients. Kidney Int. 1993;44:606. doi: 10.1038/ki.1993.287.
    1. Kaufman AM, Morris AT, Lavarias VA, Wang Y, Leung JF, Glabman MB, et al. Effects of controlled blood cooling on hemodynamic stability and urea kinetics during high-efficiency hemodialysis. J Am Soc Nephrol. 1998;9(5):877–83.
    1. Ayoub A, Finlayson M. Effect of cool temperature dialysate on the quality and patients’ perception of haemodialysis. Nephrol Dial Transplant. 2004;19(1):190–4. doi: 10.1093/ndt/gfg512.
    1. Duchesne R, Klein JD, Velotta JB, Doran JJ, Rouillard P, Roberts BR, et al. UT-A urea transporter protein in heart increased abundance during uremia, hypertension, and heart failure. Circ Res. 2001;89(2):139–45. doi: 10.1161/hh1401.093293.
    1. Yu A, Wong F, Rafiq M, Zhou F, Daugirdas J. Collection of a representative fraction of total spent hemodialysate. Am J Kidney Dis. 1995;25(5):810–2. doi: 10.1016/0272-6386(95)90560-X.
    1. Selby NM, McIntyre CW. Opinion: How should dialysis fluid Be individualized for the chronic hemodialysis patient? Semin Dial. 2008;21(3):229–31. doi: 10.1111/j.1525-139X.2008.00429.x.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel